Andrew D Levin

This inventor holds 24 USPTO granted patents and 24 published patent applications and 4 EPO patents, primarily in Hydrofoil Technology. Top assignees: Imbria Pharmaceuticals, Inc., Regent Craft Inc., Aerovate Therapeutics, Inc.. Active years: 1988-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew D Levin. Retrieved from https://idiyas.com/inventor/andrew-d-levin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 (Patent Applications = 24)

% Patents Active = 87.5

EPO Patents = 4 (Patent Applications = 19)

Average Co-Inventor Count = 1.7

ph-index = 6

Forward Citations = 89(Granted Patents)

Location History:

Cambridge, MA (US) (1988)
Newton, MA (US) (2020 - 2023)

Company Filing History:

9 out of 23

Imbria Pharmaceuticals, Inc.

Aerovate Therapeutics, Inc.

patents

4. 3 out of 3

Eliem Therapeutics, Inc.

patents

5. 1 out of 1

Arcuate Therapeutics, Inc.

patent

6. 1 out of 1

Athenen Therapeutics, Inc.

patent

7. 1 out of 1

Eliem Therapeutics (UK) Ltd

Years Active: 1988-2026

Loading Chart...

Areas of Expertise:

Hydrofoil

Seaglider

Cardiac Metabolism

Fibrosis Treatment

GABA Receptors

Chiral Peptides

Inhalable Formulations

Combination Therapy

Efficiency

Wing-in-Ground Effect

N-acylethanolamide

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12709389 - Hydrofoil Takeoff and Landing with Multiple Hydrofoils (2026-08-18),

2. 12576980 - Hydrofoil equipped seaglider takeoff (2026-03-17),

3. 12569480 - Methods of treating fibrosis using compounds that promote glucose oxidation (2026-03-10),

4. 12420924 - Hydrofoil takeoff and landing with multiple hydrofoils (2025-09-23),

5. 12330781 - Wing-in-ground effect vehicles and methods of control (2025-06-17),

6. 12318453 - Compositions and methods for increasing efficiency of cardiac metabolism (2025-06-03),

7. 12318382 - Methods of treating rheumatic diseases using trimetazidine-based compounds (2025-06-03),

8. 12116139 - Hydrofoil equipped seaglider takeoff (2024-10-15),

9. 11844840 - Compositions and methods for increasing efficiency of cardiac metabolism (2023-12-19),

10. 11806349 - Inhalable imatinib formulations, manufacture, and uses thereof (2023-11-07),

11. 11571432 - Compositions that preferentially potentiate subtypes of GABAreceptors and methods of use thereof (2023-02-07),

12. 11547681 - N-acylethanolamide derivatives and uses thereof (2023-01-10),

13. 11376330 - Compositions and methods for increasing efficiency of cardiac metabolism (2022-07-05),

14. 11298355 - Inhalable imatinib formulations, manufacture, and uses thereof (2022-04-12),

15. 11229650 - Inhalable imatinib formulations, manufacture, and uses thereof (2022-01-25),

Title: Andrew D Levin: Innovator in Cardiac and Pharmaceutical Research

Introduction

Andrew D Levin, a distinguished inventor based in Newton, MA, has made significant contributions to the fields of cardiac metabolism and pharmaceutical formulations. With a remarkable portfolio of 15 patents, Levin has established a reputation for his innovative approaches to complex medical challenges.

Latest Patents

Levin's recent inventions reflect his deep understanding of cardiovascular health and drug delivery systems. One of his notable patents is focused on compositions and methods for increasing the efficiency of cardiac metabolism. This innovation aims to enhance the metabolic processes of the heart, potentially leading to improved treatment options for cardiovascular diseases. Another significant invention is related to inhalable imatinib formulations, which outlines manufacturing methods and applications for this drug. The potential of inhalable delivery systems marks a critical advancement in the therapeutic management of various conditions.

Career Highlights

Throughout his career, Andrew D Levin has contributed to leading companies such as Imbria Pharmaceuticals, Inc. and Aerovate Therapeutics, Inc. His work at these organizations has allowed him to explore and develop groundbreaking solutions that address pressing health issues. Levin's 15 patents demonstrate a sustained commitment to innovation and research, highlighting his role as a thought leader in the medical field.

Collaborations

Collaboration has been a cornerstone of Levin's success, with noteworthy partnerships alongside colleagues such as Ben Dake and Ralph Niven. These collaborations have facilitated the exchange of ideas and fostered a research environment conducive to experimentation and discovery.

Conclusion

In summary, Andrew D Levin stands out as an accomplished inventor whose work in cardiac metabolism and innovative pharmaceutical formulations has the potential to transform healthcare. His dedication to advancing medical technology through his patents exemplifies the essence of innovation, paving the way for future breakthroughs in the industry.

Profile summary based on public USPTO records.